Avalo Therapeutics Inc (AVTX)

Apr 13, 2026

AVTX Reiterated by BTIG -- Price Target Maintained at $40 - GuruFocus

Apr 13, 2026

Apr 13, 2026

Short Squeeze: Can Avalo Therapeutics Inc grow without external funding2026 Setups & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn

Apr 13, 2026

Apr 12, 2026

Wall Street analysts predict an 113.34% upside in Avalo Therapeutics (AVTX): Here's what you should know - MSN

Apr 12, 2026

Apr 10, 2026

Breakout Move: Is Avalo Therapeutics Inc a potential multi baggerWeekly Profit Analysis & Weekly Consistent Profit Watchlists - baoquankhu1.vn

Apr 10, 2026

Apr 10, 2026

Avalo Therapeutics (NASDAQ: AVTX) sets 2026 virtual meeting and ESPP changes - Stock Titan

Apr 10, 2026

Apr 10, 2026

Death Cross: Will Avalo Therapeutics Inc be affected by tariffsWeekly Loss Report & Daily Profit Focused Screening - baoquankhu1.vn

Apr 10, 2026

Apr 10, 2026

Wolfe Research initiates coverage of Avalo Therapeutics (AVTX) with outperform recommendation - MSN

Apr 10, 2026

Apr 09, 2026

AVTX: Wolfe Research Initiates Coverage with 'Outperform' Rating - GuruFocus

Apr 09, 2026

Apr 08, 2026

Wolfe Research Initiates Avalo Therapeutics(AVTX.US) With Buy Rating, Announces Target Price $48 - Moomoo

Apr 08, 2026

Apr 08, 2026

Mittie Doyle Sells 3,970 Shares of Avalo Therapeutics (NASDAQ:AVTX) Stock - MarketBeat

Apr 08, 2026

Apr 08, 2026

Aug Closing: Is Avalo Therapeutics Inc undervalued by DCF analysis2026 Weekly Recap & Daily Chart Pattern Signal Reports - baoquankhu1.vn

Apr 08, 2026

Apr 08, 2026

Avalo Therapeutics: chief medical officer Doyle Mittie sells $71k in AVTX - Investing.com Canada

Apr 08, 2026

Apr 08, 2026

Avalo Therapeutics (AVTX) CMO exercises options, sells 3,970 shares in 10b5-1 trades - Stock Titan

Apr 08, 2026

Apr 07, 2026

Avalo Therapeutics, Inc. (AVTX) stock price, news, quote and history - Yahoo Finance UK

Apr 07, 2026

Apr 07, 2026

Citizens Initiates Coverage of Avalo Therapeutics (AVTX) with Market Outperform Recommendation - MSN

Apr 07, 2026

Apr 06, 2026

65,800-share Form 144 filed by AVTX (NASDAQ: AVTX) - Stock Titan

Apr 06, 2026

Apr 06, 2026

Zacks Industry Outlook Features Indivior Pharmaceuticals, Catalyst Pharmaceuticals, Theravance Biopharma, Relmada Therapeutics, and Avalo Therapeutics - Bitget

Apr 06, 2026

Apr 06, 2026

Zacks Industry Outlook Highlights Indivior Pharmaceuticals, Catalyst Pharmaceuticals, Theravance Biopharma, Relmada Therapeutics and Avalo Therapeutics - Zacks Investment Research

Apr 06, 2026

Apr 06, 2026

This Avalo Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Apr 06, 2026

Apr 06, 2026

Avalo Therapeutics (NASDAQ:AVTX) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

Apr 06, 2026

Apr 06, 2026

Avalo Therapeutics (NASDAQ:AVTX) Earns Market Outperform Rating from Analysts at Citizens Jmp - MarketBeat

Apr 06, 2026

Apr 06, 2026

Avalo Therapeutics Inc (AVTX) Stock News & Articles - 24/7 Wall St.

Apr 06, 2026

Apr 06, 2026

Citizens Initiates Coverage on Avalo Therapeutics (AVTX) with Ma - GuruFocus

Apr 06, 2026

Apr 06, 2026

Citizens JMP Initiates Avalo Therapeutics(AVTX.US) With Buy Rating, Announces Target Price $52 - Moomoo

Apr 06, 2026

Apr 06, 2026

Citizens initiates Avalo Therapeutics stock with outperform rating By Investing.com - Investing.com India

Apr 06, 2026

Apr 06, 2026

Citizens initiates Avalo Therapeutics stock with outperform rating - Investing.com

Apr 06, 2026

Apr 05, 2026

Avalo Therapeutics Inc at TD Cowen Healthcare Conference Transcript - GuruFocus

Apr 05, 2026

Apr 04, 2026

AVTX Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 04, 2026

Apr 04, 2026

Avalo Therapeutics, Inc. (NASDAQ:AVTX) Given Average Rating of "Moderate Buy" by Analysts - marketbeat.com

Apr 04, 2026

Apr 04, 2026

Avalo Therapeutics (AVTX) CMO Doyle Mittie sells $10,864 in stock By Investing.com - Investing.com India

Apr 04, 2026

Apr 04, 2026

Insider Sell Alert: Christopher Sullivan Sells Shares of Avalo T - GuruFocus

Apr 04, 2026

Apr 03, 2026

Avalo Therapeutics (NASDAQ:AVTX) CFO Sells $133,807.83 in Stock - MarketBeat

Apr 03, 2026

Apr 03, 2026

Avalo Therapeutics (NASDAQ:AVTX) Insider Mittie Doyle Sells 679 Shares - MarketBeat

Apr 03, 2026

Apr 03, 2026

Avalo Therapeutics (NASDAQ:AVTX) CFO Christopher Ryan Sullivan Sells 7,980 Shares - MarketBeat

Apr 03, 2026

Apr 03, 2026

Avalo Therapeutics CFO Sullivan sells $270k in stock By Investing.com - Investing.com India

Apr 03, 2026

Apr 03, 2026

Avalo Therapeutics CFO Sullivan sells $270k in stock - Investing.com

Apr 03, 2026

Apr 03, 2026

Avalo Therapeutics (AVTX) CMO Doyle Mittie sells $10,864 in stock - Investing.com

Apr 03, 2026

Apr 03, 2026

Avalo Therapeutics (AVTX) CFO executes Rule 10b5-1 stock sale plan - Stock Titan

Apr 03, 2026

Apr 03, 2026

Avalo Therapeutics (AVTX) CMO exercises options, sells 679 pre-planned shares - Stock Titan

Apr 03, 2026

Apr 03, 2026

Wall Street experts anticipate Avalo Therapeutics (AVTX) could surge by 113.34%: Key Insights You Need to Know - Bitget

Apr 03, 2026

Apr 03, 2026

Wall Street Analysts Predict an 113.34% Upside in Avalo Therapeutics (AVTX): Here's What You Should Know - Yahoo Finance

Apr 03, 2026

Apr 01, 2026

[144] Avalo Therapeutics, Inc. SEC Filing - Stock Titan

Apr 01, 2026

Apr 01, 2026

Director at Avalo Therapeutics (NASDAQ: AVTX) receives 1,339 options - Stock Titan

Apr 01, 2026

Apr 01, 2026

Director at Avalo Therapeutics (NASDAQ: AVTX) receives 1,370 vested options - Stock Titan

Apr 01, 2026

Apr 01, 2026

Logos Global (AVTX) discloses 1,285,000-share position, including options - Stock Titan

Apr 01, 2026